To assess the relationship between infant feeding practices and mortality by 18 months of age among children born to HIV-infected mothers in the Kesho Bora trial (Burkina-Faso, Kenya and South Africa).
Enrolled HIV-infected women were counseled to choose between breastfeeding up to 6 months or replacement feeding from delivery. Multivariable Cox models were used to compare the infant mortality risks according to feeding practices over time defined as never breastfed, weaned or still breastfed. The category ‘still breastfed’ was disaggregated as exclusively, predominantly or partially breastfed to compare modes of breastfeeding. The relationship between weaning and mortality was also assessed using marginal structural models to control for time-dependent confounders, such as maternal or infant morbidity (reverse causality).
Among 795 mothers, 618 (77.7%) initiated breastfeeding. Mortality rates by 18 months among uninfected and infected children were 6 and 38%, respectively. Never breastfed and weaned children were at greater risk of death compared with those still breastfed. Adjusted hazard ratios were 6.7 [95% confidence interval (CI)=2.5–17.9; P < 0.001] and 6.9 (CI = 2.8–17.2; P < 0.001) for never breastfed and weaned children, respectively. Estimation of the effect of weaning using marginal structural models led to similar results. No statistically significant differences were observed according to mode of breastfeeding (exclusive, predominant or partial).
Within 6 months after birth, weaned or never breastfed children were at about seven-fold higher risk of dying compared with children who were still breastfed despite a context in which interventions were provided to reduce risks associated with replacement feeding.
Supplemental Digital Content is available in the text
aInstitut de Recherche pour le Développement, University of Montpellier, Montpellier, France
bWHO, Reproductive Health and Research, Geneva, Switzerland
cCentre Muraz, Bobo-Dioulasso, Burkina Faso
dInternational Centre for Reproductive Health (ICRH), Mombasa, Kenya
eInternational Centre for Reproductive Health, Ghent University, Ghent, Belgium
fCentre for International Health, Burnet Institute, Melbourne, Victoria, Australia
gUniversity of KwaZulu-Natal, Durban, South Africa
hDepartment of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva, Switzerland
iAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa
jEunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland
kNVPO/OASH/OS/DHHS, Washington, DC, USA.
*The Kesho Bora Study Group members are listed in the Appendix.
Correspondence to Amandine Cournil, Institut de Recherche pour le Développement, BP 64501, 34394 Montpellier Cedex 5, France. Tel: +33 4 67 41 63 22; fax: +33 4 67 41 63 30; e-mail: email@example.com
Received 21 August, 2012
Revised 26 November, 2012
Accepted 29 November, 2012
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).